0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Cardiovascular medicine

Buy Now

Antiarrhythmic Drugs - Mechanisms of Antiarrhythmic and Proarrhythmic Actions (Paperback, Softcover reprint of the original 1st ed. 1995) Loot Price: R2,911
Discovery Miles 29 110
Antiarrhythmic Drugs - Mechanisms of Antiarrhythmic and Proarrhythmic Actions (Paperback, Softcover reprint of the original 1st...

Antiarrhythmic Drugs - Mechanisms of Antiarrhythmic and Proarrhythmic Actions (Paperback, Softcover reprint of the original 1st ed. 1995)

Gunter Breithardt; Edited by (associates) W. Haverkamp, G. Hindricks; Edited by Martin Borggrefe, John A. Camm, Mohammad Shenasa

 (sign in to rate)
Loot Price R2,911 Discovery Miles 29 110 | Repayment Terms: R273 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

The past 10 years have seen a remarkable change in the approach to cardiac arrhythmias, from a position of confidence and a feeling of well-being about pharmacological treatment to a situation in which there is now marked uncertainty and general apprehension about the role of antiarrhythmic drugs. Until relatively recently the prevailing concept in antiarrhythmic therapy was that arrhythmias could be controlled by drugs which slowed conduction or suppressed automaticity, goals well served by the sodium channel-blocking drugs and glycosides. Drug re search was based largely on the development of agents mimicking those already available, but with greater efficacy, fewer side effects or a more favourable phar macokinetic profile. The CAST trial stands out as a landmark in the evolution of arrhytmia manage ment; rarely has a single trial had such a profound impact not only on clinical prac tice, but also on the whole approach of those involved in the research, development and regulation of antiarrhythmic drugs. The results of the CAST trial, designed to redress the shortcomings of earlier trials which had failed to demonstrate the anticipated improvement in mortality post-myocardial infarction with the use of class I agents, are well known. The CAST and CAST II showed an increase in mor tality associated with the active agent (encainide, flecainide or morizicine) com pared to placebo treatment. They firmly established the potential danger in the use of class I drugs."

General

Imprint: Springer-Verlag
Country of origin: Germany
Release date: August 2012
First published: 1995
Editors: Gunter Breithardt
Associate editors: W. Haverkamp • G. Hindricks
Editors: Martin Borggrefe • John A. Camm • Mohammad Shenasa
Dimensions: 235 x 155 x 22mm (L x W x T)
Format: Paperback
Pages: 410
Edition: Softcover reprint of the original 1st ed. 1995
ISBN-13: 978-3-642-85626-6
Categories: Books > Medicine > Clinical & internal medicine > Cardiovascular medicine
Books > Medicine > Other branches of medicine > Pharmacology > General
Promotions
LSN: 3-642-85626-8
Barcode: 9783642856266

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Herbal Bioactive-Based Drug Delivery…
Inderbir Singh Bakshi, Rajni Bala, … Paperback R4,215 Discovery Miles 42 150
Membranes in Pulmonary Vascular Disease…
Patrick Belvitch, Steven Dudek Hardcover R4,690 Discovery Miles 46 900
Encyclopedia of Cardiovascular Research…
Douglas B. Sawyer, Ramachandran S. Vasan Hardcover R46,279 Discovery Miles 462 790
Have You Planned Your Heart Attack…
Warrick Bishop Hardcover R1,598 Discovery Miles 15 980
Transcatheter Mitral Valve Intervention…
Jason H Rogers Hardcover R1,793 Discovery Miles 17 930
Plaque Imaging, An Issue of Neuroimaging…
J Kevin DeMarco Hardcover R1,806 Discovery Miles 18 060
Heart Failure, An Issue of Critical…
Jennifer Kitchens Hardcover R1,790 Discovery Miles 17 900
Coronary Artery Disease, An Issue of…
David Shavelle Hardcover R1,796 Discovery Miles 17 960
Stroke Rehabilitation, An Issue of…
John Chae Hardcover R1,786 Discovery Miles 17 860
Team-Based Care for Heart Failure, An…
Gregg C. Fonarow Hardcover R1,800 Discovery Miles 18 000
Lipidology, An Issue of Cardiology…
Edward A. Gill Hardcover R1,799 Discovery Miles 17 990
Atrial Fibrillation, An Issue of…
Hakan Oral Hardcover R1,776 Discovery Miles 17 760

See more

Partners